,file,ref_number,ref_text,doi,doi_url
0,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_20,[1],"Siegel RL, Miller KD, Jemal A. 2020. CA Cancer J Clin. Colorectal cancer statistics, 2020.",10.3322/caac.21590,https://doi.org/10.3322/caac.21590
1,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_20,[2],Compton CC. 2006. Arch Pathol Lab Med. Optimal pathologic staging: defining stage II disease.,10.1158/1078-0432.ccr-07-1398,https://doi.org/10.1158/1078-0432.ccr-07-1398
2,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_20,[3],"Jayne DG, Fook S, Loi C, Seow-Choen F. 2002. Br J Surg. Peritoneal carcinomatosis from colorectal cancer.",10.1046/j.1365-2168.2002.02274.x,https://doi.org/10.1046/j.1365-2168.2002.02274.x
3,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_20,[4],"Glynne-Jones R, Wyrwicz L, Tiret E, et al. 2017. Ann Oncol. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.",10.1093/annonc/mdx224,https://doi.org/10.1093/annonc/mdx224
4,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_20,[5],"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. 2013. Nat Rev Cancer. Cancer drug resistance: an evolving paradigm.",10.1038/nrc3599,https://doi.org/10.1038/nrc3599
5,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_20,[6],"Van Cutsem E, Cervantes A, Nordlinger B, Arnold D. 2014. Ann Oncol. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.",10.1093/annonc/mdu260,https://doi.org/10.1093/annonc/mdu260
6,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_20,[7],"Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. 2006. Ann Oncol. Epidemiology and management of liver metastases from colorectal cancer.",10.1097/01.sla.0000217629.94941.cf,https://doi.org/10.1097/01.sla.0000217629.94941.cf
